false000182643500-000000000018264352023-03-132023-03-130001826435spkb:RedeemableWarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExe...
NEW YORK, March 13, 2023 (GLOBE NEWSWIRE) -- Silver Spike Acquisition Corp II (the “Company”) today announced...
false000182643500-0000000NASDAQNASDAQNASDAQ00018264352023-03-092023-03-090001826435spkb:UnitsEachConsistingOfOneClassAOrdinaryShareAndOneFourthOfOn...
false000182643500-000000000018264352023-03-032023-03-030001826435spkb:RedeemableWarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExe...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATIO...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A ...
TABLE OF CONTENTS UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a...
UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549SCHEDULE 13GUnder the Securities Exchange Act of 1934(AMENDMENT NO...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE...
false12-312022Q3000182643500-0000000P2D0.25P3D00018264352022-01-012022-09-300001826435spkb:RedeemableWarrantsMember2022-01-012022-09-300001826435us...
false000182643500-000000000018264352022-09-232022-09-230001826435spkb:UnitsEachConsistingOfOneClassAOrdinaryShareAndOneFourthOfOneRedeemableWarrant...
UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549SCHEDULE 13GUnder the Securities Exchange Act of 1934 SILVER...
Eleusis, a clinical-stage life science company that aims to unlock the therapeutic potential of psychedelics, and Silver Spike Acquisition Corp...
Filed by Eleusis Inc. Pursuant to Rule 425 under the Securities Act of 1933, and deemed filed pursuant to Rule 14a-12 under...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.